ACT Genomics was invited to visit Prof. Zhou Hai Yue’s team and laboratory at the Guangdong Academy of Medical Sciences in Guangdong General Hospital.
Place:
Guangdong
The 2018 Biomarker & Immuno-oncology World Congress in Boston brings together biopharma, molecular diagnostics companies and research institutes to discuss the development of biomarkers for immunotherapy.
Place:
USA
ACT Genomics was invited to attend InvestHK’s Reception for New Foreign and Mainland Companies in Hong Kong at the Government House on June 12th, 2018.
Place:
Hong Kong
ACT Genomics was invited to participate at the “Precision” symposium, organized by the Faculty of Health Sciences at the University of Macau, from June 8th to 9th.
Place:
Macau
ACT Genomics sponsored a seminar entitled “The Coming Era of Precision Oncology – The importance of Next-Generation Sequencing (NGS) Testing in Cancer Patient Treatment” at Queen Elizabeth Hospital on June 5th, 2018.
Place:
Hong Kong
ACT Genomics received a warm welcome by Prof. Deng Chuxia (Dean/Chair Professor of Faculty of Health Sciences, University of Macau) and his team on May 30th, 2018 in Macau.
Place:
Macau
ACT Genomics is proud to have 4 abstracts accepted for publication at 2018 ASCO! The abstracts highlight our experiences in identifying actionable alterations across different solid tumors using comprehensive genomic profiling.
Place:
USA
A lung cancer workshop is held by Taiwan Society of Pulmonary and Critical Care Medicine in Taichung to explore the latest trend in lung cancer treatment. ACT Genomics will share more about precision medicine in our display area.
Place:
Taichung
ACT Genomics is honoured to be invited to give a roundtable & symposium talk in Cebu, Philippine
Place:
Philippines
ACT Genomics is awarded the best immunotherapy solution provider in 2nd China & America Precision Medicine Forum 2018 for its research achievements in immunotherapy. ACT Genomics CSO Dr. Shu-Jen Chen will deliver a talk to elaborate on the role and applic
Place:
Shanghai